NEW YORK – First Analysis Securities on Thursday upgraded NeoGenomics' shares to Strong Buy from a prior Outperform rating after the firm's shares fell 8 percent following its Q4 earnings report and outlook.
NEW YORK – First Analysis Securities on Thursday upgraded NeoGenomics' shares to Strong Buy from a prior Outperform rating after the firm's shares fell 8 percent following its Q4 earnings report and outlook.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.